Clinical studies recruiting near Lanzhou

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · Gansu Provincial Hospital · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Lanzhou university second hospital · Pfizer · NCT07028853 Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorec
Phase 2 · Lanzhou Military Region General Hospital · Fudan University · NCT06521866 Indometacin With or Without Aggressive Intravenous Hydration to Prevent Pancreatitis After Pancreatic Extracorporeal Sho
NA · The First Hospital of Lanzhou University · Changhai Hospital · NCT07202559 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · The First Hospital of Lanzhou University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
NA · University Second Hospital · Jinling Hospital, China · NCT06118840 China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
Phase N/A · Gansu Provincial People's Hospital · Second Xiangya Hospital of Central South University · NCT05498974 A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Phase 2 · The 940th hospital of joint logistics support force of Chine · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06300320 A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Phase 1/Phase 2 · Gansu Provincial Tumor Hospital · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · The Second Hospital of Lanzhou University · Shanghai Henlius Biotech · NCT07160335 Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectiou
Phase N/A · Gansu Provincial People's Hospital · Huashan Hospital · NCT05965128 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Gansu Provincial Hospital · Eli Lilly and Company · NCT07369011 A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo
Phase 3 · The First Hospital of Lanzhou University · Tasly Pharmaceutical Group Co., Ltd · NCT06000956 Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer
Phase 1/Phase 2 · Gansu Provincial Tumor Hospital · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07367516 Chinese Psoriasis Real World Evidence Research
Phase N/A · Second Affiliated Hospital, Zhejiang University, School of M · NCT04465838 A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent
Phase 3 · Gansu Provincial Cancer Hospital · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT07003074 China HeadAche DIsorders RegiStry
Phase N/A · The Second Hospital of Lanzhou University · Beijing Tiantan Hospital · NCT05334927 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Gansu Provincial Hospital · Biogen · NCT06962800 A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-pos
Phase 1/Phase 2 · Gansu Provincial Cnacer Hospital · Antengene Biologics Limited · NCT07327229 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Lanzhou University Second Hospital · Boehringer Ingelheim · NCT07220083 Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Pro
Phase N/A · The First Hospital of Lanzhou University · Xijing Hospital · NCT07531329 Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
NA · Gansu Provincial Hospital · Peking Union Medical College Hospital · NCT05866029 Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)
NA · Gansu Provincial Hospital · Sun Yat-sen University · NCT06524427 Clinical Studies for the Treatment of Advanced Solid Tumors
Phase 1/Phase 2 · The First Hospital of Lanzhou University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06825494 The Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-management
NA · Research Site · AstraZeneca · NCT06909773 A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome
Phase 3 · Gansu Provincial Hospital of Traditional Chinese Medicine · Tasly Pharmaceutical Group Co., Ltd · NCT06696261 A Study of MI078 for Postpartum Depression
Phase 3 · Gansu Provincial Hospital of Traditional Chinese Medicine · Nanjing Minova Pharmaceutical Co., Ltd. · NCT07721961 Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Che
Phase 3 · Gansu Provincial Hospital · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07165951 Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemo
Phase 3 · Gansu Provincial Hospital · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07385703

Look up another city

Look up another condition